Krystal Biotech, Inc. - stock earnings
KRYS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 8.7 million USD | 42.1 million USD |
| 2023Q3 | 80.7 million USD | 8.6 million USD |
| 2023Q2 | -33.2 million USD | ? USD |
| 2023Q1 | -45.3 million USD | ? USD |
| 2022Q4 | -32.1 million USD | ? USD |
| 2022Q3 | -29.9 million USD | ? USD |
| 2022Q2 | -28.1 million USD | ? USD |
| 2022Q1 | -50.0 million USD | ? USD |
| 2021Q4 | -21.8 million USD | ? USD |
| 2021Q3 | -15.6 million USD | ? USD |
| 2021Q2 | -16.4 million USD | ? USD |
| 2021Q1 | -15.8 million USD | ? USD |
| 2020Q4 | -10.4 million USD | ? USD |
| 2020Q3 | -9.6 million USD | ? USD |
| 2020Q2 | -6.8 million USD | ? USD |
| 2020Q1 | -5.3 million USD | ? USD |
| 2019Q4 | -5.4 million USD | ? USD |
| 2019Q3 | -4.3 million USD | ? USD |
| 2019Q2 | -5.3 million USD | 542000 USD |
| 2019Q1 | -4.1 million USD | 583000 USD |
| 2018Q4 | -3.7 million USD | 1.0 million USD |
| 2018Q3 | -2.8 million USD | 217000 USD |
| 2018Q2 | -2.3 million USD | 173000 USD |
| 2018Q1 | -2.2 million USD | 127000 USD |
| 2017Q4 | -1.4 million USD | ? USD |
| 2017Q3 | -5.3 million USD | ? USD |
| 2017Q2 | -759000 USD | ? USD |
| 2017Q1 | -494000 USD | ? USD |
| 2016Q4 | -627000 USD | ? USD |
| 2016Q3 | -322000 USD | ? USD |
KRYS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 10.9 million USD | 50.7 million USD |
| 2022 | -140.0 million USD | ? USD |
| 2021 | -69.6 million USD | ? USD |
| 2020 | -32.2 million USD | ? USD |
| 2019 | -19.1 million USD | ? USD |
| 2018 | -10.9 million USD | 1.0 million USD |
| 2017 | -7.9 million USD | ? USD |
| 2016 | -1.2 million USD | ? USD |
KRYS
Price: $162
52 week price:
Earnings Per Share: 0.38 USD
P/E Ratio: -94.90
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 151900
Ebitda: -2.1 millionMarket Capitalization: 4.8 billion